Struggling with treatment-resistant MRSA or other Staph Infections?
Discover hope through our groundbreaking clinical trial at The Biologix Center for Optimum Health.
About the Study:
Backed by IRB support, our clinical trial seeks to consistently reproduce our early promising outcomes. Delve into our research on the virome and its role in maintaining human health.
Treatment Details:
Engage in comprehensive treatments and supportive therapies daily (Monday to Friday). Learn what to expect during your program of care.
Embark on a one-to-two-week program of care, accompanied by virtual follow-up appointments for continued support.
Experience personalized treatment with induced native phage therapy, offering a safe and non-allergenic alternative.
Goal:
Our primary goal is to combat treatment-resistant MRSA or other Staph Infections, leading to symptom alleviation and enhanced well-being.
Prerequisites:
Recent primary diagnosis via laboratory test results showing positive for one or more types of Staph or MRSA, and a commitment to retesting post-treatment.